The global Breast Imaging market was valued at USD 5.35 billion in 2024 and is projected to grow from USD 5.81 billion in 2025 to USD 11.14 billion by 2033, registering a CAGR of 8.48% during the forecast period (2025–2033). The increasing prevalence of breast cancer, growing investments in medical imaging technologies, and rising awareness regarding early disease detection are major factors driving market expansion.

Breast imaging plays a critical role in diagnosing breast-related diseases and identifying early signs of Breast Cancer. Technologies such as mammography, magnetic resonance imaging (MRI), and ultrasound are widely used to examine breast tissue for abnormalities. Additionally, advanced diagnostic tools like positron emission tomography (PET) and computed tomography (CT) scans are increasingly used to improve diagnostic accuracy and enable early treatment intervention.

Get your Sample Report to Boost Your Industry Knowledge for Valuable Insights! https://straitsresearch.com/report/breast-imaging-market/request-sample

Market Drivers

Rising Prevalence of Breast Cancer Worldwide

The increasing global incidence of breast cancer is a key driver of the breast imaging market. Early diagnosis significantly improves survival rates, making breast imaging technologies essential in healthcare systems worldwide.

According to the World Health Organization, breast cancer became the most commonly diagnosed cancer globally in recent years. By the end of 2020, approximately 7.8 million women had been diagnosed with breast cancer within the previous five years. Furthermore, around 2.26 million new cases were reported globally in 2020, highlighting the urgent need for improved screening and diagnostic solutions.

Breast imaging technologies help detect cancer at an early stage when the disease is still confined to ducts or lobules. Early detection through mammography and other imaging methods reduces mortality rates and improves treatment outcomes, significantly supporting market growth.

Increasing Investment in Breast Cancer Research and Development

Growing investments in breast cancer research and technological advancements in imaging devices are further driving the market. Governments, research institutions, and healthcare organizations worldwide are allocating significant funding to improve diagnostic technologies.

For instance, the National Cancer Institute reported that U.S. funding for breast cancer research increased by 10.5%, rising from USD 519.9 million in 2016 to USD 574.9 million in 2018. Similarly, collaborative initiatives such as the Stand Up to Cancer Canada Metastatic Breast Cancer Dream Team have been launched to support nationwide clinical trials and research efforts aimed at preventing and treating metastatic breast cancer.

These investments are fostering innovations in imaging technology, accelerating product development, and strengthening the overall breast imaging ecosystem.

Market Challenges

Risks Associated with Radiation Exposure

Despite technological advancements, certain imaging methods rely on ionizing radiation, which may pose health risks when used excessively. Techniques such as contrast-enhanced mammography (CEM), digital breast tomosynthesis (DBT), whole-breast computed tomography (WBCT), molecular breast imaging (MBI), and positron emission mammography (PEM) expose patients to radiation.

In some procedures, radioactive tracers are injected into the body, which can expose other tissues to radiation. Although the risks are generally minimal, repeated imaging or higher radiation exposure could increase long-term cancer risks. These safety concerns may hinder widespread adoption of certain imaging technologies, particularly in routine screening programs.

Market Opportunities

Growing Demand for Breast Cancer Screening in Emerging Markets

Emerging economies, particularly across the Asia-Pacific region, are expected to present significant growth opportunities for the breast imaging market. Many developing nations face challenges related to late-stage breast cancer diagnosis due to limited access to screening facilities.

Improving healthcare infrastructure, rising awareness campaigns, and government-backed screening programs are expected to increase adoption of breast imaging technologies in these regions. For example, national screening initiatives such as BreastScreen Aotearoa in New Zealand and BreastScreen Australia provide free mammography screening for women within specified age groups, encouraging early diagnosis and improving healthcare outcomes.

Such government initiatives are expanding screening coverage and strengthening diagnostic infrastructure, thereby creating strong market growth potential in developing countries.

Get Full Report with TOC: https://straitsresearch.com/report/breast-imaging-market

Regional Insights

North America

North America remains a significant market for breast imaging technologies due to the high prevalence of breast cancer and strong healthcare infrastructure. The region is expected to grow at a CAGR of 7.88% during the forecast period.

In the United States, breast cancer is one of the most common cancers among women. According to the American Cancer Society, approximately 281,550 new invasive breast cancer cases and 43,600 deaths were estimated in 2021. Such statistics emphasize the need for early detection technologies, driving demand for advanced imaging systems.

Europe

Europe is projected to experience robust growth with a CAGR of 9.19% during the forecast period. Factors such as a rapidly aging population, increasing breast cancer incidence, and well-developed healthcare systems are contributing to market growth.

In the European Union (EU-27), more than 355,000 women were diagnosed with breast cancer in 2020. With a rising elderly population and increasing cancer awareness programs, the region is witnessing growing demand for advanced diagnostic imaging technologies.

Asia-Pacific

Asia-Pacific represents a rapidly expanding market driven by rising healthcare awareness, expanding patient populations, and government investments in healthcare infrastructure. Countries such as Japan, Australia, Singapore, and Hong Kong are leading in healthcare outcomes and imaging technology adoption.

While breast cancer incidence rates remain relatively lower compared to Western countries, the number of cases is steadily increasing due to lifestyle changes, obesity, and delayed childbirth. These factors are accelerating demand for advanced breast imaging solutions across the region.

LAMEA (Latin America, Middle East, and Africa)

The LAMEA region is witnessing gradual growth due to increasing breast cancer incidence, expanding healthcare coverage, and rising health insurance penetration. In Latin America alone, approximately 115,000 women are diagnosed with breast cancer annually, highlighting the urgent need for improved diagnostic infrastructure.

However, limited healthcare access and lack of awareness in some areas continue to pose challenges to market expansion.

Market Segmentation

By Technology

The breast imaging market is segmented into ionizing and non-ionizing technologies.

The ionizing technology segment currently dominates the market and is expected to grow at a CAGR of 8.09%. Techniques such as mammography, PET-CT, molecular breast imaging, and cone beam CT utilize low-dose X-rays to detect abnormalities. In the United States alone, approximately 48 million mammograms are performed annually, demonstrating the widespread adoption of mammography as a primary screening tool.

On the other hand, non-ionizing technologies, including breast MRI, ultrasound, thermography, and optical imaging, are gaining popularity due to their lower radiation risk and ability to provide detailed soft tissue visualization.

By End User

The market is segmented into hospitals & clinics and specialty centers.

Hospitals and clinics account for the largest share and are expected to grow at a CAGR of 9.27%. Advanced diagnostic equipment such as MRI scanners, CT machines, and ultrasound devices available in hospitals enable early detection and effective treatment planning.

Specialty imaging centers are also expanding globally as healthcare systems increasingly emphasize early detection and specialized diagnostic services.

Competitive Landscape

The breast imaging market is highly competitive, with several global medical technology companies focusing on innovation, product development, and strategic partnerships to strengthen their market presence. Key players include:

• Koninklijke Philips N.V.
• General Electric Company
• Siemens Healthineers
• Fujifilm Holdings Corporation
• Hologic, Inc.
• Delphinus Medical Technologies, Inc.
• Sonocine
• Cmr Naviscan Corporation
• Planmed Oy
• Kub Technologies

These companies are focusing on integrating artificial intelligence, advanced imaging software, and improved diagnostic workflows to enhance diagnostic accuracy and efficiency.

Recent Developments

In November 2022, Koninklijke Philips N.V. introduced new AI-powered informatics solutions at the Radiological Society of North America Annual Meeting, aimed at improving diagnostic confidence throughout the radiology workflow.

In January 2023, Seno Medical Instruments entered into a distribution agreement with Genetik Inc. to expand the availability of advanced breast imaging systems.

Outlook

The global breast imaging market is poised for steady expansion as healthcare systems worldwide prioritize early cancer detection, improved diagnostic technologies, and expanded screening programs. With increasing investments in imaging innovation and growing awareness of breast cancer screening, the market is expected to witness sustained growth through 2033.